Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Proceedings of the American Thoracic Society|August 9, 2007
Migration and accumulation of effector CD4+ T cells in nonlymphoid tissuesJames B McLachlan, Marc K JenkinsVaccine Insights|October 26, 2023
Non-mucosal vaccination strategies to enhance mucosal immunityLisa A Morici, James B McLachlanThe American Journal of Pathology|June 7, 2011
Chemokine receptor requirements for epidermal T-cell traffickingNoah J Tubo, James B McLachlan, James J CampbellImmunology Letters|July 20, 2017
Salmonella infection: Interplay between the bacteria and host immune systemJonathan R Kurtz, J Alan Goggins, James B McLachlanHuman Vaccines & Immunotherapeutics|August 2, 2019
Immunological considerations in the development of Pseudomonas aeruginosa vaccinesSarah M Baker, James B McLachlan, Lisa A MoriciMethods in Molecular Biology (Clifton, N.J.)|August 20, 2005
In vivo models for studying mast cell-dependent responses to bacterial infectionChristopher P Shelburne, James B McLachlan, Soman N AbrahamPathogens (Basel, Switzerland)|July 30, 2020
Control of Persistent Salmonella Infection Relies on Constant Thymic Output Despite Increased Peripheral Antigen-Specific T Cell ImmunityJ Alan Goggins, Jonathan R Kurtz, James B McLachlanVaccine|March 9, 2024
Current vaccine strategies and novel approaches to combatting Francisella infectionJaikin E Harrell, Chad J Roy, John S Gunn, et al.Immunity|February 10, 2009
Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skinJames B McLachlan, Drew M Catron, James J Moon, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2013
CD4+ T cell persistence and function after infection are maintained by low-level peptide:MHC class II presentationRyan W Nelson, James B McLachlan, Jonathan R Kurtz, et al.Pageof 5